Disparity of the Efficacy of DPP-4 Inhibitors in Combination with Metformin vs. High Dose Metformin as Initial Treatment between Asian and Caucasian T2DM Patients

被引：0

|

作者：

Huang, Xiuting

Gao, Xueying

Cai, Xiaoling

Ji, Linong

机构：

来源：

DIABETES | 2018年 / 67卷

关键词：

D O I：

10.2337/db18-1188-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页数：2

相关论文

共 50 条

[1] DPP-4 inhibitors tolerable option for T2DM patients
Reactions Weekly, 2017, 1667 (1) : 5 - 5
[2] Repaglinide/metformin fixed-dose combination tablet vs. rosiglitazone/metformin fixed-dose combination tablet in T2DM subjects evaluated by prior OAD treatment regimen
Rhee, Chanhaeng
Hang, Yaming
Lyness, William
Raskin, Philip
DIABETES, 2008, 57 : A586 - A587
[3] Risk of Diabetic Retinopathy in Type 2 Diabetes Patients Treated with DPP-4 Inhibitor and Metformin vs. Sulfonylurea and Metformin
Yang, Bo Ram
Kim, Ye-jee
Shin, Ju-Young
Kim, Mi-Sook
Park, Byung-Joo
Lee, Joongyub
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 368 - 368
[4] A DECISION-FOCUSED MIXED TREATMENT COMPARISON (MTC) OF ALTERNATIVE DPP-4 INHIBITORS (DPP-4I'S) USED IN COMBINATION WITH METFORMIN OR A SULFONYLUREA FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM)
Tolley, K.
Strickson, A.
Kay, S.
Benson, E.
Selby, R.
VALUE IN HEALTH, 2014, 17 (07) : A334 - A334
[5] Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Perez, Alfonso
Zhao, Zhen
Jacks, Randal
Spanheimer, Robert
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (12) : 2915 - 2923
[6] Efficacy and Safety of Metformin Glycinate vs. Metformin Hydrochloride in Metabolic Control and Inflammatory Mediators in Type 2 Diabetes Mellitus Patients (T2DM)
Gonzalez-Canudas, Jorge
DIABETES, 2019, 68
[7] Glycemic Improvement with Fixed-Dose Combination of DPP-4 Inhibitor plus Metformin in Patients with Type 2 DM (GIFT Study)
Bajaj, Harpreet S.
Aronson, Ronnie
Venn, Karri
Stein, Eden
Ye, Chenglin
DIABETES, 2014, 63 : A610 - A610
[8] Efficacy and safety of empagliflozin as an add on to metformin and DPP4 inhibitor in T2DM patients, fasting during Ramadan
Pathan, M. F.
Akter, N.
Selim, S.
Saifuddin, M.
Qureshi, N. K.
Hasan, A. B. M. K.
Hannan, M. A.
Ahmed, M. A. U.
Mustari, M.
Chakraborty, A. K.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
[9] The Efficacy and Safety of SGLT2 Inhibitor vs. Placebo as Add-on Therapy in Patients with T2DM and Inadequate Glycemic Control with Metformin and a DPP-4 Inhibitor: Systematic Review and Meta-analysis
Javaid, Muhammad
Rana, Zaid
Liew, Aaron
DIABETES, 2017, 66 : LB45 - LB45
[10] The DPP-4 inhibitor, LAF237, improves glycemic control in patients with type 2 diabetes (T2DM) inadequately treated with metformin
Ahren, B
Gomis, R
Mills, D
Schweizer, A
DIABETES, 2004, 53 : A83 - A83

← 1 2 3 4 5 →